CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Lab Expectations listing page

Read More

Andrea Tu, PhD

Andrea Tu, PhD

Andrea Tu, PhD, is a Scientific Marketing Manager at Kallidus Group who geeks out when learning about the latest scientific trends and developments. She received a PhD in Molecular and Cell Biology from the University of California, Berkeley where she studied Smad post-translational modifications in the TGF-β signaling pathway. Over the course of 20 years, Andrea has worked at UC San Diego, the Salk Institute, Stanford, Agilent Technologies, and Bio-Techne in technical roles spanning R&D, sales support, and marketing.

Recent Posts:

Beyond Your Primary Antibody: What You Need for a Successful Chromatin Profiling Experiment

If you’ve performed CUT&RUN, CUT&Tag, or ChIP/ChIP-seq experiments, you know how important i...
Andrea Tu, PhD May 8, 2024

CUT&Tag DNA Library Yield: What to Do if Yours Is Too Low to Detect with an Agilent Bioanalyzer or TapeStation System

Chromatin profiling with methods like ChIP-Seq, CUT&RUN, and now CUT&Tag have significantly ...
Andrea Tu, PhD Feb 5, 2024

Breast Cancer Awareness Month: What You Need to Know About the BRCA Gene

Each year, approximately 13% of all women in the US and 25% of all women globally will feel their he...
Andrea Tu, PhD Oct 23, 2023

Identify New Immuno-Oncology Strategies Faster with Rapid, One-Step T Cell Activation & Expansion Kits

The success of immuno-oncology therapeutics has opened the door to novel cancer elimination strategi...
Andrea Tu, PhD Sep 20, 2023

Cancer Immunotherapy Awareness Month: Fueling the Next Scientific Breakthrough

Did you know June is Cancer Immunotherapy Research Awareness Month? This year, we’ll celebrate 10 ye...
Andrea Tu, PhD Jun 21, 2023

Therapeutic Approaches for the Treatment of Multiple Myeloma

Multiple myeloma is a cancer of plasma cells that is treatable, but not curable. In this blog, we re...
Andrea Tu, PhD Jul 2, 2022

Novel Therapeutic Approaches for Diffuse Large B-Cell Lymphoma

Lymphoma is a cancer of the lymphatic system, a principal part of the body’s immune system. Lymphoma...
Andrea Tu, PhD May 11, 2022

Pancreatic Cancer: Targeting Novel Drivers in the Tumor Microenvironment

Pancreatic cancer is devastating and difficult to diagnose early. The organ is located deep inside t...
Andrea Tu, PhD Apr 27, 2022

Melanoma: Aberrant Signaling Pathways and Therapeutic Approaches

There are three major types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melan...
Andrea Tu, PhD Mar 30, 2022

Emerging Therapeutic Approaches for Prostate Cancer

Approximately 1 in 8 men will be diagnosed with prostate cancer, a disease which accounts for the se...
Andrea Tu, PhD Feb 23, 2022

Why Do We Love Conjugation? Ask Reggie!

Reggie Prioli, Associate Director of Conjugation at Cell Signaling Technology® (CST®), has been conj...
Andrea Tu, PhD Feb 14, 2022

Tools for Classifying Cells and Identifying Protein Localization

When do I want to classify cells? Why do I care where a protein localizes? These are actually two di...
Andrea Tu, PhD Jan 26, 2022

Analyzing PTM Activation State Using Western Blotting

Post-translational modifications (PTMs) are a critical regulatory mechanism that allows cells to tig...
Andrea Tu, PhD Dec 8, 2021

Tools for Modulating Cells

Cell behavior is a tightly regulated, finely tuned process where various different signals work toge...
Andrea Tu, PhD Oct 13, 2021

Tools for Monitoring Cell State

Have you been wondering how to monitor a cell state or cellular response? From a basic research stan...
Andrea Tu, PhD Oct 6, 2021

    Related Posts